Claim/exemption information - Registry number 11882
List of suggested corrective measures
Correct the disclosure of misleading cross-referencing between SDS sections.
Correct the disclosure of misleading information regarding personal protective equipment in case of accidental release.
Correct the precautionary statements to select the appropriate phrase(s) when a slash is present.
Disclose a clear link between all of the applicable confidential business information and the HMIRA registry number.
Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.
Disclose an adequate product odour.
Disclose incompatibilities of the hazardous product.
Disclose that the ingredient “benzene, C10-16-alkyl derivatives” has been shown to cause reproductive toxicity effects.
Disclose the actual concentrations of the ingredients or a statement to the effect that the actual concentrations are withheld as a trade secret.
Disclose the additional hazard classification of “Reproductive Toxicity — Category 2”.
Disclose the additional information elements in section 4, “First-aid measures”.
Disclose the additional ingredient “benzene, C10-16-alkyl derivatives”.
Disclose the applicable common names and synonyms for the ingredient “diethylene glycol monobutyl ether”.
Disclose the information elements concerning the additional hazard and precautionary statements.
Disclose the likely routes of exposure in section 11, “Toxicological information”.
Disclose the percent of unknown toxicity for the calculated product oral and inhalation ATE values.
Disclose the product’s relative density.
Disclose the symbol and/or name of the symbol for “Health hazard” on the SDS.